Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil

Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil

Abstract Background Eradication of hepatitis C virus (HCV) using direct-acting agents (DAA) has been associated with a financial burden to health authorities worldwide. We aimed to evaluate the guideline-based treatment costs by DAAs from the perspective of the Brazilian Ministry of Health (BMoH). M...

Full description

Bibliographic Details
Main Authors: Hugo Perazzo, Marcelino Jose Jorge, Julio Castro Silva, Alexandre Monken Avellar, Patrícia Santos Silva, Carmen Romero, Valdilea Gonçalves Veloso, Ruben Mujica-Mota, Rob Anderson, Chris Hyde, Rodolfo Castro
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Gastroenterology
Subjects:
Chronic hepatitis C
Treatment
Micro-costing
Online Access:http://link.springer.com/article/10.1186/s12876-017-0676-8

Internet

http://link.springer.com/article/10.1186/s12876-017-0676-8

Similar Items